Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group

Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group

US Patent 7608271 · Granted Oct 27, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical formulations and methods for the treatment of gastrointestinal di2025
Cardioversion methods using budiodarone2025
Methods for reducing the risk of strokes by pharmacotherapy to reduce the number2024
Methods for reducing the risk of strokes by pharmacotherapy to reduce the number2024
Methods for reducing the risk of strokes by pharmacotherapy to reduce the number2023
Methods for the treatment of gastro-intestinal disorders2023
Methods for reducing the risk of strokes by pharmacotherapy to reduce the number2023
Pharmaceutical composition comprising plasminogen and uses thereof2023
Methods for the treatment of gastro-intestinal disorders2022
Process for the preparation of a dodecapeptide2022
Plasminogen replacement therapy for plasminogen-deficiency2022
Methods of preventing toxicity of platinum drugs2021